Literature DB >> 21226726

IL-17 and Regulatory Cytokines (IL-10 and IL-27) in L. braziliensis Infection.

R Novoa1, O Bacellar, M Nascimento, T M Cardoso, R Ramasawmy, W N Oliveira, A Schriefer, E M Carvalho.   

Abstract

Cutaneous leishmaniasis (CL) is characterized by high production of pro-inflammatory cytokines and development of pathology. Individuals with subclinical L. braziliensis infection (SC) have a positive skin test to leishmania, but do not develop disease. We evaluated whether the downregulation of inflammatory response in SC is mediated by IL-10 and IL-27 and whether IL-17 is associated with control of infection. Participants include SC individuals, patients with CL and healthy subjects. Cytokines protein and mRNA were detected by ELISA and real-time PCR. IFN-γ and TNF-α levels were higher in CL than in SC group. The IL-10 levels and mRNA for IL-10 were similar in both SC and CL. mRNA for IL-27 was increased in cells from SC after stimulation with L. braziliensis antigen. There was a tendency for increased levels of IL-17 in SC compared to CL. The weak type 1 immune response observed in SC L. braziliensis infection is not because of the regulatory effects of IL-10 and IL-27. The control of Leishmania infection may be mediated by innate immune response with participation of IL-17. The results from this pilot study warrant further larger studies to investigate the potential contributions of IL-17 and IL-27 to the control of L. braziliensis infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21226726      PMCID: PMC3077537          DOI: 10.1111/j.1365-3024.2010.01256.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  21 in total

Review 1.  The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses.

Authors:  Giorgio Trinchieri; Stefan Pflanz; Robert A Kastelein
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

2.  IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice.

Authors:  John E Pearl; Shabaana A Khader; Alejandra Solache; Leigh Gilmartin; Nico Ghilardi; Fred deSauvage; Andrea M Cooper
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

3.  Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism.

Authors:  Takeru Yoshimura; Atsunobu Takeda; Shinjiro Hamano; Yoshiyuki Miyazaki; Ichiko Kinjyo; Tatsuro Ishibashi; Akihiko Yoshimura; Hiroki Yoshida
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

4.  Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity.

Authors:  K Maasho; F Sanchez; E Schurr; A Hailu; H Akuffo
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis.

Authors:  C I Brodskyn; A Barral; V Boaventura; E Carvalho; M Barral-Netto
Journal:  J Immunol       Date:  1997-11-01       Impact factor: 5.422

6.  The predictive validity of naturally acquired delayed-type hypersensitivity to leishmanin in resistance to Leishmania major-associated cutaneous leishmaniasis.

Authors:  Afif Ben Salah; Hechmi Louzir; Sadok Chlif; Mourad Mokni; Amor Zaatour; Mohamed Raouene; Riadh Ben Ismail; Koussay Dellagi
Journal:  J Infect Dis       Date:  2005-10-21       Impact factor: 5.226

7.  The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis.

Authors:  Christoph Hölscher; Alexandra Hölscher; Dominik Rückerl; Takayuki Yoshimoto; Hiroki Yoshida; Tak Mak; Christiaan Saris; Stefan Ehlers
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

8.  Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis.

Authors:  T C Jones; W D Johnson; A C Barretto; E Lago; R Badaro; B Cerf; S G Reed; E M Netto; M S Tada; T F Franca
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

9.  Selection of a skin test antigen for American visceral leishmaniasis.

Authors:  S G Reed; R Badaró; H Masur; E M Carvalho; R Lorenco; A Lisboa; R Teixeira; W D Johnson; T C Jones
Journal:  Am J Trop Med Hyg       Date:  1986-01       Impact factor: 2.345

10.  The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection.

Authors:  Alejandro Villarino; Linda Hibbert; Linda Lieberman; Emma Wilson; Tak Mak; Hiroki Yoshida; Robert A Kastelein; Christiaan Saris; Christopher A Hunter
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

View more
  33 in total

1.  Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis.

Authors:  Luiz Felipe Domingues Passero; Ana Kely Carvalho; Maria Luiza A C Bordon; Alexis Bonfim-Melo; Marcos Hikari Toyama; Carlos Eduardo Pereira Corbett; Márcia Dalastra Laurenti
Journal:  Inflamm Res       Date:  2011-12-14       Impact factor: 4.575

2.  Characterization of regulatory T cell (Treg) function in patients infected with Leishmania braziliensis.

Authors:  Diego L Costa; Luiz H Guimarães; Thiago M Cardoso; Adriano Queiroz; Ednaldo Lago; Ana M Roselino; Olívia Bacellar; Edgar M Carvalho; João S Silva
Journal:  Hum Immunol       Date:  2013-08-28       Impact factor: 2.850

Review 3.  Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.

Authors:  Lynn Soong; Calvin A Henard; Peter C Melby
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

4.  Cytokine responses to novel antigens in a peri-urban population in Brazil exposed to Leishmania infantum chagasi.

Authors:  Carmel B Stober; Selma M B Jeronimo; Nubia N Pontes; E Nancy Miller; Jenefer M Blackwell
Journal:  Am J Trop Med Hyg       Date:  2012-07-23       Impact factor: 2.345

5.  Tr-1-like CD4+CD25-CD127-/lowFOXP3- cells are the main source of interleukin 10 in patients with cutaneous leishmaniasis due to Leishmania braziliensis.

Authors:  Diego L Costa; Tiago M Cardoso; Adriano Queiroz; Cristiane M Milanezi; Olívia Bacellar; Edgar M Carvalho; João S Silva
Journal:  J Infect Dis       Date:  2014-08-19       Impact factor: 5.226

6.  Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.

Authors:  Thiago Marconi Cardoso; Álvaro Machado; Diego Luiz Costa; Lucas P Carvalho; Adriano Queiroz; Paulo Machado; Phillip Scott; Edgar M Carvalho; Olívia Bacellar
Journal:  Infect Immun       Date:  2014-12-22       Impact factor: 3.441

7.  Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort Study.

Authors:  Aline C Muniz; Olívia Bacellar; Ednaldo Lima Lago; Augusto M Carvalho; Pedro Paulo Carneiro; Luiz Henrique Guimarães; Paulo N Rocha; Lucas P Carvalho; Marshall Glesby; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2016-05-18       Impact factor: 5.226

8.  The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection.

Authors:  Allison Ehrlich; Tiago Moreno Castilho; Karen Goldsmith-Pestana; Wook-Jin Chae; Alfred L M Bothwell; Tim Sparwasser; Diane McMahon-Pratt
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

9.  Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice.

Authors:  Leo A B Joosten; Fátima Ribeiro-Dias; Rodrigo Saar Gomes; Muriel Vilela Teodoro Silva; Jéssica Cristina Dos Santos; Christine van Linge; Juliana Machado Reis; Mauro Martins Teixeira; Sebastião Alves Pinto; Miriam Leandro Dorta; Xiyuan Bai; Edward D Chan; Charles A Dinarello; Milton Adriano Pelli Oliveira
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

Review 10.  Immunoregulation in human American leishmaniasis: balancing pathology and protection.

Authors:  K J Gollob; A G Viana; W O Dutra
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.